Search Results 251-260 of 17221 for peptide protocols

  1. Publications - Juan C. Diaz Soto, M.D. - Mayo Clinic

    Analysis of The 2024 ESC/EACTS Guidelines For The Management Of Atrial Fibrillation. ... Rabbit serum against K1 peptide, an immunogenic epitope of the ...

  2. EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study) - Mayo Clinic

    Sponsor Protocol Number: Pro00071722 ... Peptide (NT-proBNP) levels, which reflect ... Guidelines differ from study to study, and identify who can or cannot ...

  3. Neuromuscular Intervention Targeted to Mechanisms of ACL Load in Athletes - Mayo Clinic

    ... protocols following initial ACL reconstruction and prior to return to sport. As nearly one-third of athletes who have a primary ACL injury and return to ...

  4. A Study to Evaluate the Effectiveness of a Dexamethasone Eluting Slim Modiolar Electrode in the Reduction of Fibrosis in a Newly Implanted Adult Population with Bilateral, Post-Linguistic, Moderate to Profound Sensorineural Hearing Loss - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  5. Clinical trials - Oncology (Medical)

    Patients' tumors will be sequenced during a pre-registration component or will have had successful sequencing pre-study. A personalized neoantigen peptide ...

  6. Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Health Topics - Mayo Clinic News Network

    Mayo Clinic Q&A podcast: Protection protocols involving ear, nose and throat patients during COVID. COVID-19. Mayo Clinic Q&A podcast: Protection protocols ...

  8. Hematology - Clinical trials

    The aim of this study is to study the efficacy and safety of our short and long one-day protocols for TMP-SMX graded administration in hematologic ...

  9. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

    Sponsor Protocol Number: CAAA603D12101 ... peptide receptor positive, estrogen receptor ... Guidelines differ from study to study, and identify who can or cannot ...

  10. Clinical trials - Oncology (Medical)

    ... protocol and patient consent for participation in this protocol. The collected tissue specimens will be used to develop preclinical models; i.e., cell lines ...